Andoy, Robella .
HRN: 17-28-16 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2026
02/13/2026
IV
1 Gram
Single Dose
For CS
Checking Initial Appropriateness
02/15/2026
MUPIROCIN 2%, 15G (TUBE)
02/15/2026
02/22/2026
TOPICAL
Apply To Post Op Site
OD
SP 1LTCS
Checking Initial Appropriateness